Health Care

Analyst Recommendation about Healthcare Stock: Johnson & Johnson (NYSE:JNJ)


Johnson & Johnson (NYSE:JNJ) closed its last session at $117.86 with the change of +0.21%. The market capitalization of the company is $322.45B with an average Volume of 6.68 million shares. The stock currently has its 52-Week High range of $126.07 and 52-week low range of $89.90. The Price to Book (P/B) ratio stands at 4.44. The stock traded total quantity of 6.12 million shares.

Currently Johnson & Johnson (JNJ) captured an average recommendation of “ Overweight ” from analysts, according to FactSet data. The stock has been suggested as “Buy” from “9″ Analysts”. “0” rated “Sell” for the company. “12” said the company as a “Hold”. Overweight rating was given by “2” and Underweight rating was given by “0”.

Analysts are expecting that the company to achieve $126.44 Price Target in next 52-weeks, average price is come up through the consensus of analysts. High potential price target is set at $142.00 however minimum price target advised by analysts is $105.00. The Median price target for the stock is measured at $128.00.

Presently, Analysts decided consensus EPS estimate of $1.65 for present quarter and one month ago projected EPS estimate was at $1.65. If we take a look at back 3 month ago, consensus EPS estimate was $1.65.

A current consensus EPS estimate for next quarter is at $1.57 and 3 month ago EPS forecast was $1.59. Have a look at back 1 month ago, consensus EPS forecast was seen at $1.58.

For current fiscal year, most recent EPS estimate is set at $6.68 based on Analyst consensus and three month ago consensus EPS opinions was at $6.60. During period one month ago, consensus EPS forecast was decided at $6.69.

A current consensus EPS projection for next fiscal year is observed at $7.10 and one month ago consensus EPS forecast was at $7.10. Take a look at back three month ago, consensus EPS estimate opinions was decided at $7.00 by analysts.

One Month ago, the stock has gained consensus mean rating of Overweight based on the analysis of brokerage analyst firms polled. 9 presented the recommendations about the stock as a “Buy” signal and “Overweight” signal was reported by 2. 12 advised the “Hold” rating about this stock. 0 revealed “Sell” signal and “Underweight” rating was declared by 0.

Three Months Ago, Analysts recommended an average brokerage rating of Overweight derived from brokerage firms, according to FactSet. 9 said a “Buy Rating” and 2 announced “Overweight Rating”. 13 advised “Hold Rating” regarding the stock. 0 announced “Sell Rating” and 0 disclosed “Underweight Rating”.

About the author / 

Leave a reply

Your email address will not be published. Required fields are marked *

About Us

WSnews4investors is the influential source for financial news and Opinion Company with content which delivered over the Internet. WSnews4investors is a dynamic and innovative financial media outlet that empowers investors with high-quality, unique content that is coveted by Wall Street’s traders.